Literature DB >> 2509594

[A case of Plasmodium vivax malaria complicated with pancytopenia due to hypoplasia of the bone marrow].

H Yamakawa, M Kiyotaki, Y Hattori, M Obana, Y Matsuoka, S Irimajiri.   

Abstract

The patient is a 39 year-old Japanese male who had traveled to Southeast Asia from March 14, 1987 and returned on April 2. On April 3 and 5, he had a high fever with chills and he was admitted to our hospital. Despite initial treatment with antibiotics, a high fever over 39 degrees C appeared with a 48 hour periodicity. On the 8th day after admission, malarial parasites were identified on the peripheral blood smear after repeated trials. Combined with a raised serum antibody titer, Plasmodium vivax malaria was diagnosed. He was successfully treated with the sulfadoxine 500 mg and pyrimethamine 25 mg (Fansidar) and body temperature was normalized after the 12th day. More interestingly, the patient showed pancytopenia without splenomegaly. The bone marrow aspiration revealed hypoplasia of erythroblasts, granulocytes and megakaryocytes. Because of this pancytopenia in the peripheral blood and hypoplasia of the bone marrow which improved after recovery from malarial infection, it was indicated that they were caused by the malarial infection. Generally, it is considered that anemia in malarial patients is caused by destruction of the blood cells by parasites and/or hypersplenism and compensatory hyperplasia of the bone marrow is seen. On the contrary, this case showed pancytopenia accompanied with hypoplasia of the bone marrow probably due to the malarial infection suggesting a new aspect of pathogenesis in the hematological abnormality of the malarial infection.

Entities:  

Mesh:

Year:  1989        PMID: 2509594     DOI: 10.11150/kansenshogakuzasshi1970.63.1043

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  3 in total

1.  Plasmodium vivax inhibits erythroid cell growth through altered phosphorylation of the cytoskeletal protein ezrin.

Authors:  Tasanee Panichakul; Saranyoo Ponnikorn; Sittiruk Roytrakul; Atchara Paemanee; Suthathip Kittisenachai; Suradej Hongeng; Rachanee Udomsangpetch
Journal:  Malar J       Date:  2015-03-31       Impact factor: 2.979

2.  Suppression of erythroid development in vitro by Plasmodium vivax.

Authors:  Tasanee Panichakul; Witchuda Payuhakrit; Panyu Panburana; Chokdee Wongborisuth; Suradej Hongeng; Rachanee Udomsangpetch
Journal:  Malar J       Date:  2012-05-24       Impact factor: 2.979

3.  Acute Plasmodium vivax malaria presenting with pancytopenia secondary to hemophagocytic syndrome: case report and literature review.

Authors:  Waleed Albaker
Journal:  J Family Community Med       Date:  2009-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.